Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B
Alessandro Loglio(Ospedale Papa Giovanni XXIII), Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Angelo Sangiovanni(Ospedale Maggiore), G. Grossi(University of Milan), M. Colombo(University of Milan), Massimo Iavarone(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), F. Facchetti(University of Milan), Maria Grazia Rumi(University of Milan), G. Lunghi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Mauro Viganò(Ospedale San Giuseppe)
Cited by 7
Related Papers
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
The natural history of compensated cirrhosis due to hepatitis C virus
|Hepatology|2006|631
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆
|Gastroenterology|2004|607